Skip to content

Phacoemulsification and changes in outflow facility

Phacoemulsification and changes in outflow facility in eyes with and without glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN04247738
Enrollment
40
Registered
2009-12-22
Start date
2010-01-18
Completion date
Unknown
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

1. Visual acuity: using Snellen chart 2. Slit-lamp examination: including examination of the cornea for development of any signs of stromal oedema, gonioscopy using Zeiss or Goldmann gonioscopy lens

Sponsors

Guy's and St. Thomas' NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged greater than 21 years 2. Lens opacity deemed enough to be causing reduced vision 3. Diagnosis of primary open angle glaucoma (POAG) (Group 1) or no glaucoma (Group 2). POAG defined as glaucomatous optic neuropathy together with an intraocular pressure (IOP) greater than 21 mmHg on at least one occasion, visual field defects (using the 24-2 test pattern on a Humphrey Field Analyser) and a gonioscopic angle width of 3 or 4 and normal in appearance. 4. Patient's willingness to participate in the study and ability to give informed consent

Exclusion criteria

Exclusion criteria: 1. Previous intraocular surgery 2. Previous ocular trauma that can cause damage to the drainage angle (e.g. angle recession) 3. International normalised ratio (INR) greater than 3.0 on the day of surgery (for the patients on warfarin) 4. Anterior segment neovascularisation 5. Chronic use of systemic or topical steroid 6. Any other concurrent ocular disease e.g. uveitis, diabetic retinopathy, corneal diseae, etc.

Design outcomes

Primary

MeasureTime frame
Outflow facility is measured using electronic Shiotz tonography at 3, 6 and 12 months post cataract surgery

Secondary

MeasureTime frame
1. Anterior chamber depth is measured using IOL master at baseline 2. Intraocular pressure is measured using Goldmann applanation tonometer at baseline, 3, 6 and 12 months 3. Intra- or post-operative complications is measured using clinically intra-operatively and post operatively 4. Development of glaucoma is measured using clinically and Humphrey visual field at baseline and 12 months

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 24, 2026